Your browser doesn't support javascript.
loading
Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traits.
Küçükali, Fahri; Neumann, Alexander; Van Dongen, Jasper; De Pooter, Tim; Joris, Geert; De Rijk, Peter; Ohlei, Olena; Dobricic, Valerija; Bos, Isabelle; Vos, Stephanie J B; Engelborghs, Sebastiaan; De Roeck, Ellen; Vandenberghe, Rik; Gabel, Silvy; Meersmans, Karen; Tsolaki, Magda; Verhey, Frans; Martinez-Lage, Pablo; Tainta, Mikel; Frisoni, Giovanni; Blin, Oliver; Richardson, Jill C; Bordet, Régis; Scheltens, Philip; Popp, Julius; Peyratout, Gwendoline; Johannsen, Peter; Frölich, Lutz; Freund-Levi, Yvonne; Streffer, Johannes; Lovestone, Simon; Legido-Quigley, Cristina; Kate, Mara Ten; Barkhof, Frederik; Zetterberg, Henrik; Bertram, Lars; Strazisar, Mojca; Visser, Pieter Jelle; Van Broeckhoven, Christine; Sleegers, Kristel.
Afiliação
  • Küçükali F; Complex Genetics of Alzheimer's Disease Group, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium.
  • Neumann A; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
  • Van Dongen J; Complex Genetics of Alzheimer's Disease Group, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium.
  • De Pooter T; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
  • Joris G; Complex Genetics of Alzheimer's Disease Group, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium.
  • De Rijk P; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
  • Ohlei O; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
  • Dobricic V; Neuromics Support Facility, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium.
  • Bos I; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
  • Vos SJB; Neuromics Support Facility, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium.
  • Engelborghs S; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
  • De Roeck E; Neuromics Support Facility, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium.
  • Vandenberghe R; Lübeck Interdisciplinary Platform for Genome Analytics (LIGA), University of Lübeck, Lübeck, Germany.
  • Gabel S; Lübeck Interdisciplinary Platform for Genome Analytics (LIGA), University of Lübeck, Lübeck, Germany.
  • Meersmans K; Netherlands Institute for Health Services Research, Utrecht, Netherlands.
  • Tsolaki M; Alzheimer Centrum Limburg, Maastricht University, Maastricht, Netherlands.
  • Verhey F; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
  • Martinez-Lage P; Department of Neurology and Brussels Integrated Center for Brain and Memory (Bru-BRAIN), Universitair Ziekenhuis Brussel (UZ Brussel) and Center for Neurosciences (C4N), Vrije Universiteit Brussel (VUB), Brussels, Belgium.
  • Tainta M; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
  • Frisoni G; Department of Neurology and Memory Clinic, Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken, Antwerp, Belgium.
  • Blin O; University Hospital Leuven, Leuven, Belgium.
  • Richardson JC; Department of Neurosciences, Laboratory for Cognitive Neurology, KU Leuven, Leuven, Belgium.
  • Bordet R; University Hospital Leuven, Leuven, Belgium.
  • Scheltens P; University Hospital Leuven, Leuven, Belgium.
  • Popp J; Department of Neurosciences, Laboratory for Cognitive Neurology, KU Leuven, Leuven, Belgium.
  • Peyratout G; 1st Department of Neurology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Makedonia, Thessaloniki, Greece.
  • Johannsen P; Alzheimer Centrum Limburg, Maastricht University, Maastricht, Netherlands.
  • Frölich L; Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, Netherlands.
  • Freund-Levi Y; School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands.
  • Streffer J; Center for Research and Advanced Therapies, CITA-Alzheimer Foundation, San Sebastian, Spain.
  • Lovestone S; Center for Research and Advanced Therapies, CITA-Alzheimer Foundation, San Sebastian, Spain.
  • Legido-Quigley C; Department of Psychiatry, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland.
  • Kate MT; RCCS Instituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
  • Barkhof F; Clinical Pharmacology & Pharmacovigilance Department, Marseille University Hospital, Marseille, France.
  • Zetterberg H; Neurosciences Therapeutic Area, GlaxoSmithKline R&D, Stevanage, United Kingdom.
  • Bertram L; Neuroscience & Cognition, CHU de Lille, University of Lille, Inserm, France.
  • Visser PJ; Alzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, Netherlands.
  • Van Broeckhoven C; Department of Geriatric Psychiatry, University Hospital of Psychiatry Zürich, Zürich, Switzerland.
  • Sleegers K; Department of Psychiatry, Old Age Psychiatry, University Hospital of Lausanne, Lausanne, Switzerland.
Alzheimers Dement ; 19(6): 2317-2331, 2023 06.
Article em En | MEDLINE | ID: mdl-36464806
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article